Retransplantation in children.
Evaluation of 75 cadaver donor retransplants revealed that the primary factor influencing allograft survival is patient responsiveness as reflected by sensitization with preformed cytotoxic antibodies. Actuarial allograft survival rates for nonpresensitized (less than 5%) and moderately presensitized (5-50%) recipients were significantly (p less than 0.001) better than those of highly presensitized (greater than 50%) recipients. Although HLA antigen histocompatibility did not have a statistically significant effect on retransplant outcome, it appeared to influence allograft survival in the highly presensitized recipient. An approach to the management of children who lose an initial or subsequent allograft is indicated by these data.
D000293:Adolescent; D000906:Antibodies; D003601:Cytotoxicity Tests, Immunologic; D006084:Graft Rejection; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007674:Kidney Diseases / Q000401:mortality; D016030:Kidney Transplantation; D008297:Male; D013997:Time Factors; D014184:Transplantation, Homologous
D000906:Antibodies